CHS-0214

DRUG3 trials

Sponsors

Coherus Oncology, Inc.

Conditions

Plaque PsoriasisRheumatoid Arthritis

Phase 3

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)

CompletedNCT02115750

Coherus Oncology, Inc.Rheumatoid Arthritis

Start: 2014-05-31End: 2016-05-31Updated: 2019-06-26

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

CompletedNCT02134210

Coherus Oncology, Inc.Plaque Psoriasis

Start: 2014-06-16End: 2016-05-12Updated: 2019-06-28

A Long Term Safety Extension Study (CHS-0214-05)

CompletedNCT02486939

Coherus Oncology, Inc.Plaque Psoriasis, Rheumatoid Arthritis

Start: 2015-07-31End: 2017-10-31Updated: 2018-12-27